Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Ovarian Research
Published in: Journal of Ovarian Research 1/2011

Open Access 01-12-2011 | Research

Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors

Authors: Michael J Bradaric, Animesh Barua, Krishna Penumatsa, Yu Yi, Seby L Edassery, Sameer Sharma, Jacques S Abramowicz, Janice M Bahr, Judith L Luborsky

Published in: Journal of Ovarian Research | Issue 1/2011

Login to get access

Abstract

Background

Sphingosine-1 receptor 1 (S1P1) plays a major role in regulating lymphocyte egress from peripheral lymph tissue. Lymphocyte trafficking is potentially a critical response to tumors and to tumor vaccines. Also, the receptor has been shown to influence metastasis. However, there is little information on its expression in the aged ovary or ovarian tumors. As a basis for further studies in the laying hen model of spontaneous ovarian cancer, the objective of this study was to determine if S1P1 is expressed in hens, and if the morphological distribution of S1P1 is similar in hen and human ovary and ovarian tumors.

Methods

S1P1 mRNA was ascertained in hen tissue by RT-PCR using hen specific primers. S1P1 protein expression and localization was evaluated in hen and human tissue with a human S1P1 antibody by Western blot and immunohistochemistry.

Results

S1P1 mRNA was expressed in all hen tissues examined. Protein was detected in human and hen ovary and ovarian tumors at 47, 72 and 108 kDa in Western blots. S1P1 was similarly expressed on endothelial cells, lymphocytes and surface epithelial cells in normal ovaries and tumor-containing ovaries of the hen. In addition, S1P1 distribution was heterogeneous in both hen and human ovarian tumors by immunohistochemistry.

Conclusion

The results show that S1P1 is expressed in the hen and human ovary as well as in ovarian tumors. These findings support the use of the hen in further studies of the role of S1P1 in metastasis and immune cell trafficking in ovarian tumor development.
Appendix
Available only for authorised users
Literature
1.
Brinkmann V, Pinschewer D, Chiba K, Feng L: FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol Sci 2000, 21: 49–52. 10.1016/S0165-6147(99)01419-4PubMedCrossRef
2.
Brinkmann V: Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 2007, 115: 84–105. 10.1016/j.pharmthera.2007.04.006PubMedCrossRef
3.
Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, et al.: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277: 21453–21457. 10.1074/jbc.C200176200PubMedCrossRef
4.
Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, et al.: The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. J Cell Biochem 2007, 101: 259–270. 10.1002/jcb.21181PubMedCrossRef
5.
Chiba K, Matsuyuki H, Maeda Y, Sugahara K: Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cell Mol Immunol 2006, 3: 11–19.PubMed
6.
Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, et al.: Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427: 355–360. 10.1038/nature02284PubMedCrossRef
7.
Goetzl EJ, Kong Y, Mei B: Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol 1999, 162: 2049–2056.PubMed
8.
Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, et al.: Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000, 106: 951–961. 10.1172/JCI10905PubMedCentralPubMedCrossRef
9.
Brinkmann V: FTY720: mechanism of action and potential benefit in organ transplantation. Yonsei Med J 2004, 45: 991–997.PubMedCrossRef
10.
Devine KM, Smicun Y, Hope JM, Fishman DA: S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. Gynecol Oncol 2008, 110: 237–245. 10.1016/j.ygyno.2008.04.013PubMedCentralPubMedCrossRef
11.
Smicun Y, Reierstad S, Wang FQ, Lee C, Fishman DA: S1P regulation of ovarian carcinoma invasiveness. Gynecol Oncol 2006, 103: 952–959. 10.1016/j.ygyno.2006.06.036PubMedCrossRef
12.
Hancke K, Strauch O, Kissel C, Gobel H, Schafer W, Denschlag D: Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil Steril 2007, 87: 172–177. 10.1016/j.fertnstert.2006.06.020PubMedCrossRef
13.
Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, et al.: Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 2000, 6: 1109–1114. 10.1038/80442PubMedCrossRef
14.
Barua A, Yoshimura Y: Ovarian autoimmunity in relation to egg production in laying hens. Reproduction 2001, 121: 117–122. 10.1530/rep.0.1210117PubMedCrossRef
15.
Barua A, Abramowicz JS, Bahr JM, Bitterman P, Dirks A, Holub KA, et al.: Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans? J Ultrasound Med 2007, 26: 909–919.PubMed
16.
Barua A, Edassery SL, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, et al.: Prevalence of antitumor antibodies in laying hen model of human ovarian cancer. Int J Gynecol Cancer 2009, 19: 500–507. 10.1111/IGC.0b013e3181a39db1PubMedCentralPubMedCrossRef
17.
Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, et al.: Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 2009, 19: 531–539. 10.1111/IGC.0b013e3181a41613PubMedCentralPubMedCrossRef
18.
Barua A, Bitterman P, Bahr JM, Bradaric MJ, Hales DB, Luborsky JL, et al.: Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer. J Ultrasound Med 2010, 29: 173–182.PubMedCentralPubMed
19.
Hales DB, Zhuge Y, Lagman JA, Ansenberger K, Mahon C, Barua A, et al.: Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen ( Gallus domesticus ). Endocrine 2008, 33: 235–244. 10.1007/s12020-008-9080-zPubMedCentralPubMedCrossRef
20.
Johnson PA, Giles JR: Use of genetic strains of chickens in studies of ovarian cancer. Poult Sci 2006, 85: 246–250.PubMedCrossRef
21.
Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE: Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 2001, 81: 373–379. 10.1006/gyno.2001.6191PubMedCrossRef
22.
23.
Bahr J: The Chicken as Model Organism. In Sourcebook of Models for Biomedical Research. Edited by: Conn PM. SpringerLink; 2008:161–167. full_textCrossRef
24.
Bahr J: The avian ovary: model for endocrine studies. J Exp Zool Suppl 1990, 4: 192–194. 10.1002/jez.1402560441PubMedCrossRef
25.
Lovell TM, Gladwell RT, Groome NP, Knight PG: Ovarian follicle development in the laying hen is accompanied by divergent changes in inhibin A, inhibin B, activin A and follistatin production in granulosa and theca layers. J Endocrinol 2003, 177: 45–55. 10.1677/joe.0.1770045PubMedCrossRef
26.
Goodman MT, Howe HL, Tung KH, Hotes J, Miller BA, Coughlin SS, et al.: Incidence of ovarian cancer by race and ethnicity in the United States, 1992–1997. Cancer 2003, 97: 2676–2685. 10.1002/cncr.11349PubMedCrossRef
27.
Giles JR, Olson LM, Johnson PA: Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 2006, 231: 1718–1725.
28.
Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, Whitaker R, et al.: Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phila) 2009, 2: 114–121. 10.1158/1940-6207.CAPR-08-0065CrossRef
29.
Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE: CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 2007, 104: 192–198. 10.1016/j.ygyno.2006.07.024PubMedCrossRef
30.
Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM, et al.: E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol 2009, 113: 362–369. 10.1016/j.ygyno.2009.02.011PubMedCentralPubMedCrossRef
31.
Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, Hales DB, et al.: Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 2008, 109: 115–121. 10.1016/j.ygyno.2007.12.030PubMedCentralPubMedCrossRef
32.
Yi Yu, Edassery SL, Barua A, Bitterman P, Abramowicz JS, Bahr JM, Hellstrom I, Luborsky JL: Mesothelin expression in ovarian tumors and serum autoantibodies of the laying hen model is similar to human ovarian cancer [abstract # 3264]. In Proceedings of the 101st Annual Meeting of the American Association for Cancer Research: 17–21 April 2010. Washington, DC. Cadmus Publishing; 2010:793.
33.
Barnes MN, Berry WD, Straughn JM, Kirby TO, Leath CA, Huh WK, et al.: A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol Oncol 2002, 87: 57–63. 10.1006/gyno.2002.6806PubMedCrossRef
34.
Chan MM, Chen CL, Ager LL, Cooper MD: Identification of the avian homologues of mammalian CD4 and CD8 antigens. J Immunol 1988, 140: 2133–2138.PubMed
35.
Cooper MD, Peterson RD, Good RA: Delineation of the Thymic and Bursal Lymphoid Systems in the Chicken. Nature 1965, 205: 143–146. 10.1038/205143a0PubMedCrossRef
36.
Davison TF: The immunologists' debt to the chicken. Br Poult Sci 2003, 44: 6–21. 10.1080/0007166031000085364PubMedCrossRef
37.
Luborsky J: Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med 2002, 11: 585–599. 10.1089/152460902760360540PubMedCrossRef
38.
Barua A, Bradaric MJ, Kebede T, Espionosa S, Edassery SL, Bitterman P, et al.: Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer. Am J Reprod Immunol 2007, 57: 243–249. 10.1111/j.1600-0897.2007.00470.xPubMedCrossRef
39.
Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, DeCherney A: Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990, 70: 69–75. 10.1210/jcem-70-1-69PubMedCrossRef
40.
Akiyama T, Sadahira Y, Matsubara K, Mori M, Igarashi Y: Immunohistochemical detection of sphingosine-1-phosphate receptor 1 in vascular and lymphatic endothelial cells. J Mol Histol 2008, 39: 527–533. 10.1007/s10735-008-9193-yPubMedCrossRef
41.
Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, et al.: Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci 2007, 27: 12012–12024. 10.1523/JNEUROSCI.3281-07.2007PubMedCrossRef
42.
Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, et al.: Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 2001, 276: 33697–33704. 10.1074/jbc.M104441200PubMedCrossRef
43.
Van Brocklyn JR, Behbahani B, Lee NH: Homodimerization and heterodimerization of S1P/EDG sphingosine-1-phosphate receptors. Biochim Biophys Acta 2002, 1582: 89–93.PubMedCrossRef
44.
Kohno T, Wada A, Igarashi Y: N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization. FASEB J 2002, 16: 983–992. 10.1096/fj.01-0809comPubMedCrossRef
45.
Choi CH, Jeong JS, Yoo BI, Jin YX, Moon DC, Yoo HS, et al.: Sphingosine 1-phosphate and sphingosine kinase activity during chicken embryonic development. Arch Pharm Res 2007, 30: 502–506. 10.1007/BF02980226PubMedCrossRef
46.
Crousillac S, Colonna J, McMains E, Dewey JS, Gleason E: Sphingosine-1-phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells. J Neurophysiol 2009, 102: 3295–3309. 10.1152/jn.00119.2009PubMedCentralPubMedCrossRef
47.
de Visser KE: Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both? Cancer Immunol Immunother 2008, 57: 1531–1539. 10.1007/s00262-008-0501-xPubMedCrossRef
48.
Milne K, Kobel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, et al.: Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One 2009, 4: e6412. 10.1371/journal.pone.0006412PubMedCentralPubMedCrossRef
49.
Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, et al.: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005, 102: 18538–18543. 10.1073/pnas.0509182102PubMedCentralPubMedCrossRef
50.
Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al.: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003, 348: 203–213. 10.1056/NEJMoa020177PubMedCrossRef
Metadata
Title
Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors
Authors
Michael J Bradaric
Animesh Barua
Krishna Penumatsa
Yu Yi
Seby L Edassery
Sameer Sharma
Jacques S Abramowicz
Janice M Bahr
Judith L Luborsky
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2011
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/1757-2215-4-4

Other articles of this Issue 1/2011

Journal of Ovarian Research 1/2011 Go to the issue

Case report

Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: a case report

Research

Differential hRad17 expression by histologic subtype of ovarian cancer

Research

MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells

Research

Luteal blood flow in patients undergoing GnRH agonist long protocol

Research

A retrospective analysis of clinicopathological and prognostic characteristics of ovarian tumors in the State of Espírito Santo, Brazil

Review

On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research